15 May 2024
SAVILLS PLC
('the Company')
ANNUAL GENERAL MEETING - 15 May 2024 RESOLUTIONS
The Savills plc Annual General Meeting was held on Wednesday 15 May 2024 at 33 Margaret Street, London, W1G 0JD. All resolutions were passed on a poll
An analysis of the proxy votes lodged against each resolution prior to the AGM is set out below:
|
Resolution
|
No. of Votes For |
% For |
No. of Votes Against |
% Against |
Total No. of Votes Cast |
Total No. of Votes Withheld/ Abstentions |
Poll Yes/No |
|
|
1 |
|
112,444,072 |
100.00% |
345 |
0.00% |
112,444,417 |
456,174 |
Yes |
|
2 |
To approve the Directors' Remuneration Report (other than the Directors' Remuneration Policy) contained in the 2023 Annual Report and Accounts |
111,905,042 |
99.12% |
994,109 |
0.88% |
112,899,151 |
1,440 |
Yes |
|
3 |
To declare a final dividend of 13.9p per ordinary share |
112,898,013 |
100.00% |
2,000 |
0.00% |
112,900,013 |
578 |
Yes |
|
4 |
To re-elect Stacey Cartwright as a Director |
107,687,737 |
95.39% |
5,209,441 |
4.61% |
112,897,178 |
3,413 |
Yes |
|
5 |
To re-elect Mark Ridley as a Director |
106,097,246 |
93.98% |
6,800,708 |
6.02% |
112,897,954 |
2,637 |
Yes |
|
6 |
To re-elect Simon Shaw as a Director |
107,325,089 |
95.06% |
5,572,866 |
4.94% |
112,897,955 |
2,636 |
Yes |
|
7 |
To re-elect Florence Tondu-Mélique as a Director |
104,832,567 |
92.86% |
8,065,390 |
7.14% |
112,897,957 |
2,634 |
Yes |
|
8 |
To re-elect Dana Roffman as a Director |
104,729,686 |
92.77% |
8,168,069 |
7.23% |
112,897,755 |
2,836 |
Yes |
|
9 |
To re-elect Philip Lee as a Director |
104,833,294 |
92.86% |
8,064,663 |
7.14% |
112,897,957 |
2,634 |
Yes |
|
10 |
To re-elect Richard Orders as a Director |
104,727,753 |
92.76% |
8,169,204 |
7.24% |
112,897,957 |
2,634 |
Yes |
|
11 |
To re-appoint Marcus Sperber as a Director |
104,832,213 |
92.86% |
8,064,644 |
7.14% |
112,896,857 |
3,734 |
Yes |
|
12 |
To re-appoint John Waters as a Director |
111,387,922 |
98.66% |
1,508,937 |
1.34% |
112,896,859 |
3,732 |
Yes |
|
13 |
To re-appoint Adriana Karaboutis as a Director |
111,405,092 |
98.68% |
1,485,767 |
1.32% |
112,890,859 |
9,732 |
Yes |
|
14 |
To re-appoint Ernst & Young as the Auditors |
112,894,578 |
100.00% |
3,891 |
0.00% |
112,898,469 |
2,122 |
Yes |
|
15 |
To authorise the Directors to determine the Auditors' remuneration |
112,899,118 |
100.00% |
1,034 |
0.00% |
112,900,152 |
439 |
Yes |
|
16 |
To renew the Directors' power to allot shares |
106,190,615 |
94.06% |
6,709,534 |
5.94% |
112,900,149 |
442 |
Yes |
|
17 |
To authorise a general disapplication of statutory pre-emption rights # |
106,393,407 |
94.24% |
6,504,390 |
5.76% |
112,897,797 |
2,794 |
Yes |
|
18 |
To authorise an additional disapplication of statutory pre-emption rights# |
105,990,000 |
93.88% |
6,907,694 |
6.12% |
112,897,694 |
2,897 |
Yes |
|
19 |
To renew the Company's authority to purchase its own shares # |
112,781,516 |
99.99% |
13,579 |
0.01% |
112,795,095 |
105,496 |
Yes |
|
20 |
To authorise the Directors to call general meetings on 14 clear days' notice # |
105,158,705 |
93.14% |
7,740,952 |
6.86% |
112,899,657 |
934 |
Yes |
# Passed as a special resolution.
NOTES:
All resolutions were passed
1. Votes 'withheld' have not been included in the calculation of whether a resolution is carried. Percentages have been rounded to two decimal places.
2. Copies of Resolutions 17 to 20 , will be submitted to the National Storage Mechanism and in due course will be available to view at http://data.fca.org.uk/#/nsm/nationalstoragemechanism using Savills plc's code 'SVS'.
3. Details of the votes received on the resolutions are available on the Company's website: http://ir.savills.com/shareholder-information/agm
4. The issued share capital was 144,545,061 ordinary shares of 2.5 pence each and the total number of voting rights in respect of these ordinary shares was 144,545,061 each ordinary share having one vote.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
